ストックスクリーナーアプリを入手
10.63
0.28%
0.03
アフターアワーズ：
10.67
0.04
+0.38%
前日終値:
$10.60
開ける：
$10.62
24時間の取引高:
3.91M
Relative Volume:
0.87
時価総額：
$1.75B
収益：
$596.34M
当期純損益:
$-87.84M
株価収益率:
-17.79
EPS:
-0.5975
ネットキャッシュフロー:
$-97.62M
1週間 パフォーマンス:
+5.14%
1か月 パフォーマンス:
+12.61%
6か月 パフォーマンス:
+13.81%
1年 パフォーマンス:
+27.46%
1日の値動き範囲:
$10.34
$10.79
1週間の範囲:
$10.15
$11.09
52週間の値動き範囲:
$6.20
$11.97
Novavax Inc Stock (NVAX) Company Profile
Compare NVAX vs VRTX, REGN, MRNA, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
10.63 | 1.75B | 596.34M | -87.84M | -97.62M | -0.5975 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-24 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-08-28 | 再開されました | H.C. Wainwright | Buy |
| 2025-08-20 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2025-06-17 | 開始されました | Citigroup | Sell |
| 2025-02-28 | 開始されました | BTIG Research | Buy |
| 2024-07-30 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2024-05-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-05-10 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-08-09 | アップグレード | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | 繰り返されました | B. Riley Securities | Buy |
| 2022-12-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2022-12-02 | 開始されました | Jefferies | Hold |
| 2022-09-22 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2022-05-20 | 開始されました | BofA Securities | Underperform |
| 2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
| 2022-02-22 | 再開されました | Jefferies | Buy |
| 2022-01-21 | 開始されました | Cowen | Outperform |
| 2021-05-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-12-14 | 開始されました | Jefferies | Buy |
| 2020-08-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-08-05 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-08-05 | ダウングレード | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-08 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | 繰り返されました | B. Riley FBR | Buy |
| 2020-06-29 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-05 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-05-28 | 繰り返されました | B. Riley FBR | Buy |
| 2020-05-12 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-04-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-27 | 再開されました | B. Riley FBR | Buy |
| 2019-08-14 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-02-28 | ダウングレード | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | 開始されました | Ladenburg Thalmann | Buy |
| 2018-12-11 | 開始されました | Oppenheimer | Outperform |
| 2018-11-26 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | アップグレード | JP Morgan | Underweight → Overweight |
| 2018-03-29 | アップグレード | Seaport Global Securities | Neutral → Buy |
すべてを表示
Novavax Inc (NVAX) 最新ニュース
(NVAX) Volatility Zones as Tactical Triggers - Stock Traders Daily
NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash - Stocktwits
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - stocktwits.com
Enterprise value to EBIT forward of Novavax, Inc. – BX:NVV1 - TradingView
Novavax stock falls 2.59 percent below its yearly high - AD HOC NEWS
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax stock falls 2.54 percent below its yearly high - AD HOC NEWS
Novavax Inc (NVAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Novavax Inc. Stock Rises 4.0%, Outperforms Peers - webull.com
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax, Inc. (NVAX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Novavax, Inc. (NVV1.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
Novavax stock gains as Q2 2026 revenue rises and vaccine focus deepens - AD HOC NEWS
Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue - Stocktwits
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Novavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock? - Yahoo Finance
Do Novavax’s (NVAX) New Partnerships Offset Policy Risks From The Protecting Approved Care Act? - Yahoo Finance
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know - Yahoo Finance
Novavax Inc. stock underperforms Tuesday when compared to competitors - marketwatch.com
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - finance.yahoo.com
Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know - Yahoo Finance
Novavax (NVAX) Laps the Stock Market: Here's Why - Yahoo Finance
ETFs Investing in Novavax, Inc. Stocks - TradingView
Novavax Inc Lobbyists, 2020 - opensecrets.org
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot - TradingView
Transcript : Novavax, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-10-2026 10:00 AM - marketscreener.com
Novavax at Citi summit: partnerships extend cash runway By Investing.com - Investing.com India
Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference - Yahoo Finance
Novavax at cantor healthcare conference: pivot to licensing gains steam - investing.com
Novavax at cantor healthcare conference: pivot to licensing gains steam By Investing.com - Investing.com Canada
NVAX: Strategic shift to licensing and Matrix-M partnerships drives growth in vaccines and oncology - TradingView
NVAX: Major pharma partnerships, Matrix-M expansion, and global commercialization drive future growth - TradingView
GOOGL Stock Price TodayAlphabet Inc Class A News, Charts, Retail Sentiment - Stocktwits
Novavax Inc (NVAX) 財務データ
収益
当期純利益
現金流量
EPS
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):